NEUE Overview

Merger Announcement: NeueHealth, Inc. has successfully merged with an affiliate of New Enterprise Associates (NEA) at an enterprise value of approximately $1.465 billion, with common stockholders receiving $7.33 per share in cash.

Leadership and Future Plans: The executive leadership team of NeueHealth will continue in their roles, having entered into rollover agreements to maintain their equity interests, as the company aims to enhance its value-driven, consumer-centric healthcare model.

Earnings Conference Call: NeueHealth, Inc. held its Q2 2025 earnings conference call on August 7, 2025, led by CEO Mike Mikan and CFO Jay Matushak, discussing the company's financial performance and future outlook.

Forward-Looking Statements: The call included forward-looking statements that are subject to risks and uncertainties, with a reminder for listeners to refer to SEC filings for detailed risk factors.

Investigation of Companies: Halper Sadeh LLC is investigating NeueHealth, Brookline Bancorp, and Nordstrom for potential violations of federal securities laws and breaches of fiduciary duties related to their recent sales.

Shareholder Rights: The law firm encourages shareholders from these companies to contact them for information on their legal rights and options, offering services on a contingent fee basis.

Insider Trading Activity: Jeffrey J Scherman, Chief Accounting Officer of $NEUE, sold 375 shares for approximately $2,598, marking a 2.7% reduction in his holdings, while insiders have conducted 27 sales and no purchases over the past six months.

Institutional Investor Movements: In the latest quarter, 6 institutional investors increased their positions in $NEUE stock, whereas 19 reduced their holdings, indicating mixed sentiment among institutional stakeholders.

Insider Trading Activity: Jeffrey J Scherman, Chief Accounting Officer of $NEUE, sold 184 shares for approximately $1,299, representing about 2.0% of his holdings, with no insider purchases reported in the last six months.

Institutional Investor Movements: In the recent quarter, 6 institutional investors increased their positions in $NEUE stock while 19 reduced theirs, indicating mixed sentiment among larger shareholders.

Earnings Report Announcement: NeueHealth, Inc. will report its fourth quarter and full year 2024 financial results on March 20, 2025, followed by a conference call at 8:00 AM ET, with options for telephone participation and a webcast available.

Company Overview: NeueHealth is a value-driven healthcare company focused on providing high-quality, coordinated care to over 500,000 consumers through clinics and partnerships, aiming to enhance accessibility and affordability in the healthcare system.